North America miRNA Sequencing and Assay Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Library Preparation and Consumables), Technology (Sequencing by Synthesis, Nanopore, and Ion Semiconductor Sequencing), and End User (Research Institute, Academia, and CRO)

No. of Pages: 115    |    Report Code: TIPRE00022179    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America miRNA Sequencing and Assay Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America miRNA Sequencing and Assay Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America miRNA Sequencing and Assay Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Expansion of technologically advanced sequence analysis platforms
5.2 Market Opportunities
  • 5.2.1 Role of miRNA in immune response regulation
5.3 Future Trends
  • 5.3.1 Rising adoption of miRNA sequencing in healthcare industry
5.4 Impact of Drivers and Restraints

6. North America miRNA Sequencing and Assay Market Regional Analysis

6.1 North America miRNA Sequencing and Assay Market Overview
6.2 North America miRNA Sequencing and Assay Market Revenue 2017-2027 (US$ Million)
6.3 North America miRNA Sequencing and Assay Market Forecast Analysis

7. North America miRNA Sequencing and Assay Market Analysis – by Product

7.1 Library Preparation
  • 7.1.1 Overview
  • 7.1.2 Library Preparation: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Consumables
  • 7.2.1 Overview
  • 7.2.2 Consumables: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2031 (US$ Million)

8. North America miRNA Sequencing and Assay Market Analysis – by Technology

8.1 Sequencing Synthesis
  • 8.1.1 Overview
  • 8.1.2 Sequencing Synthesis: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Nanopore
  • 8.2.1 Overview
  • 8.2.2 Nanopore: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Ion Semiconductor Sequencing
  • 8.3.1 Overview
  • 8.3.2 Ion Semiconductor Sequencing: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

9. North America miRNA Sequencing and Assay Market Analysis – by End User

9.1 Research Institute
  • 9.1.1 Overview
  • 9.1.2 Ion Semiconductor Sequencing: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Academia
  • 9.2.1 Overview
  • 9.2.2 Ion Semiconductor Sequencing: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.3 CRO
  • 9.3.1 Overview
  • 9.3.2 Ion Semiconductor Sequencing: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)

10. North America miRNA Sequencing and Assay Market – North America Analysis

10.1 North America
  • 10.1.1 North America miRNA Sequencing and Assay Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 North America miRNA Sequencing and Assay Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America miRNA Sequencing and Assay Market Breakdown, by Product
    • 10.1.1.1.2 US: North America miRNA Sequencing and Assay Market Breakdown, by Technology
    • 10.1.1.1.3 US: North America miRNA Sequencing and Assay Market Breakdown, by End User
  • 10.1.1.2 Canada: North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America miRNA Sequencing and Assay Market Breakdown, by Product
    • 10.1.1.2.2 Canada: North America miRNA Sequencing and Assay Market Breakdown, by Technology
    • 10.1.1.2.3 Canada: North America miRNA Sequencing and Assay Market Breakdown, by End User
  • 10.1.1.3 Mexico : North America miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America miRNA Sequencing and Assay Market Breakdown, by Product
    • 10.1.1.3.2 Mexico : North America miRNA Sequencing and Assay Market Breakdown, by Technology
    • 10.1.1.3.3 Mexico : North America miRNA Sequencing and Assay Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America miRNA Sequencing and Assay Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Illumina, Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 QIAGEN
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Perkin Elmer, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Takara Bio Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 New England Biolabs
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Norgen Biotek Corp
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 TriLink BioTechnologies Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Lexogen GmbH
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Oxford Nanopore Technologies
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America miRNA Sequencing and Assay Market

  1. Illumina, Inc
  2. THERMO FISHER SCIENTIFIC INC.
  3. QIAGEN
  4. Perkin Elmer, Inc.
  5. Takara Bio Inc.
  6. New England Biolabs
  7. Norgen Biotek Corp
  8. TriLink BioTechnologies Inc.
  9. Lexogen GmbH
  10. Oxford Nanopore Technologies
north-america-mirna-sequencing-and-assay-market